Daihan Pharm share jumps on stock market

Published: 2007-02-20 06:56:00
Updated: 2007-02-20 06:56:00
Daehan Pharm's stock rose sharply after its successful completion of preclinical trials over a degenerative arthritis medication on February 12.

Daehan gained 395 won to 3,030 won on February 14.

Daihan said it has preclinically studied a new degenerative osteoarthritis drug, which found to...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.